Skip to main content

Blog

Aesthetic Surgery Journal Open Forum
by Lisa Orozco
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
Patricia McGuire, MD
by Lisa Orozco
The dues support the 30+ ongoing studies that have been funded by The Foundation including studies such as “Cytotoxicity of Implant-Exposed Serum on Breast Cancer”, “Impact of Xeomin, Dysport, and Botox on Nerve Injuries”, “Effect of Intramuscular Fat Grafting on New Muscle Formation”, “Does TXA reduce Bruising After Hyaluronic Acid Filler Injection: A Prospective half face study”, “Increasing SMAS Durability via Photochemical Passivation for Facelifts”, and “Histologic Effects of Energy-Based Skin Tightening Treatments”.
Tracy Pfeifer, MD, MS
by Lisa Orozco
In this update, Dr. Pfeifer recaps key highlights from The Aesthetic MEET in Austin, shares insights from attending APS Korea, issues an important cybersecurity warning for plastic surgeons, and previews the upcoming Aesthetic Interactive: Facial & Rhinoplasty Symposium in Boca Raton, Florida.